APO-CANDESARTAN recall in Canada: product quality issue
In plain language
This recall involves APO-CANDESARTAN tablets sold in Canada. It's being recalled because the active ingredient was out of specification for dissolution. Consult your healthcare provider if you have concerns about this product.
What to do
- Verify if your product is affected.
- Consult your healthcare provider before stopping use.
- Contact the recalling firm with questions.
- Report any health product side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
APO-CANDESARTAN TABLETS
Lot: PTF5493B, PTG1028A, PTG0761A
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: PTF5493B, PTG1028A, PTG0761A
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves APO-CANDESARTAN tablets sold in Canada. It's being recalled because the active ingredient was out of specification for dissolution. Consult your healthcare provider if you have concerns about this product.
What should consumers do?
Verify if your product is affected. Consult your healthcare provider before stopping use. Contact the recalling firm with questions. Report any health product side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on February 16, 2026.
Is the APO-CANDESARTAN brand affected by this recall?
Yes, APO-CANDESARTAN products are affected by this recall. This recall involves APO-CANDESARTAN tablets sold in Canada. It's being recalled because the active ingredient was out of specification for dissolution. Consult your healthcare provider if you have concerns about this product.